ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for elderly blood cancer patients: major trial tests drug to make transplants more effective
Disease control Recruiting nowThis study is for people over 50 with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are getting a stem cell transplant. It compares two different drug combinations used to prepare the body for the transplant. The goal is to see if adding a drug called venetoc…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Doctors test tailored doses to make cancer transplants safer
Disease control Recruiting nowThis study is testing a personalized approach to stem cell transplants for people with blood cancers like leukemia and lymphoma. Doctors will adjust the strength of the chemotherapy and radiation given before the transplant based on each patient's specific health and disease risk…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC